Alvotech USA Inc. et al v. Abbvie Inc et al
Case Number:
1:21-cv-05645
Court:
Nature of Suit:
Judge:
Honorable Rebecca R. Pallmeyer
Firms
Companies
Sectors & Industries:
-
March 09, 2022
Alvotech, AbbVie Deal Allows For Humira Biosimilar In 2023
Icelandic biopharmaceutical firm Alvotech has settled an intellectual property fight with AbbVie Inc. over Alvotech's proposed biosimilar version of AbbVie's blockbuster drug Humira, which is used to treat arthritis and other conditions.
-
October 22, 2021
Virginia Judge Ships Suit Over AbbVie's Humira To Illinois
A Virginia federal judge on Friday transferred a declaratory judgment suit from a potential AbbVie Inc. rival hoping to make a biosimilar of its blockbuster immunosuppressant Humira to Illinois, saying the transfer order rendered a bid by AbbVie for dismissal moot.